tiprankstipranks
Trending News
More News >
Grace Therapeutics (GRCE)
NASDAQ:GRCE

Compare Grace Therapeutics (GRCE) vs. Competitors

Compare
1,173 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Grace Therapeutics
$3.51
$54.31M
-6.00
0.86%
1 Buy
0 Hold
0 Sell
Moderate Buy
Generation Bio
$5.61
$37.60M
-0.60
-34.74%
1 Buy
2 Hold
0 Sell
Moderate Buy
PolyPid
$4.72
$75.03M
-1.58
58.05%
3 Buy
0 Hold
0 Sell
Strong Buy
Aligos Therapeutics
$8.12
$49.60M
-0.41
-66.11%
3 Buy
0 Hold
0 Sell
Strong Buy
MiNK Therapeutics
$12.54
$58.86M
-4.04
85.53%
1 Buy
0 Hold
0 Sell
Moderate Buy
Cadrenal Therapeutics, Inc.
$12.92
$17.91M
-0.93
-59.76%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GRCE
Grace Therapeutics
3.51
0.33
10.38%
GBIO
Generation Bio
5.61
-2.52
-30.98%
PYPD
PolyPid
4.71
1.72
57.53%
ALGS
Aligos Therapeutics
8.12
-15.62
-65.82%
INKT
MiNK Therapeutics
12.25
5.35
77.72%
CVKD
Cadrenal Therapeutics, Inc.
7.46
-11.57
-60.80%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts